The shift from QSR to QMSR represents a major regulatory change for medical device organizations. In 2026, the FDA is no longer focused solely on a trail of paperwork; it is evaluating whether ...
The Bloomberg MAC3 GRM suite of Multi-Asset risk models incorporates a number of advanced techniques that result in superior performance across portfolio types, geographies and investment styles.